ID

31071

Descrizione

Zevalin and BEAM High-dose Chemotherapy Compared With BEAM Alone as Conditioning Regimen in Patients With Chemosensitive Relapse of Non-Hodgkin's Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00463463

collegamento

https://clinicaltrials.gov/show/NCT00463463

Keywords

versioni (1)
  1. 17/07/18 17/07/18 -
Titolare del copyright

See clinicaltrials.gov

Caricato su

17 luglio 2018

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Non-Hodgkin's Lymphoma NCT00463463

Inglese

Eligibility Non-Hodgkin's Lymphoma NCT00463463

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. patients with cd20 positive aggressive non-hodgkin's lymphoma, either diffuse large b-cell or transformed follicular lymphoma as confirmed by a pathological biopsy report.
Descrizione

Aggressive Non-Hodgkin Lymphoma CD20 positive | Diffuse Large B-Cell Lymphoma | Transformation Follicular Lymphoma | Pathology biopsy report

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1332225
UMLS CUI [1,2]
C3888518
UMLS CUI [2]
C0079744
UMLS CUI [3,1]
C0040682
UMLS CUI [3,2]
C0024301
UMLS CUI [4]
C3165547
2. patients who are candidates for stem-cell transplantation due to refractory disease to first line chemotherapy or relapsing disease and comply with standard transplant eligibility criteria.
Descrizione

Stem cell transplantation Anticipated | First line Chemotherapy Refractory Disease | Recurrent disease | Transplantation Eligibility Criteria Fulfill

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1504389
UMLS CUI [1,2]
C3840775
UMLS CUI [2,1]
C1708063
UMLS CUI [2,2]
C0392920
UMLS CUI [2,3]
C1514815
UMLS CUI [3]
C0277556
UMLS CUI [4,1]
C0040732
UMLS CUI [4,2]
C1516637
UMLS CUI [4,3]
C1550543
3. patients must have chemo-sensitive disease achieving at least partial response to salvage chemotherapy.
Descrizione

Chemosensitive malignant neoplastic disease | Partial response Salvage Chemotherapy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C4520514
UMLS CUI [2,1]
C1521726
UMLS CUI [2,2]
C0085405
UMLS CUI [2,3]
C0392920
4. patients were given up to 2 lines of therapy, initial treatment and one salvage treatment. local radiation therapy for consolidation is not considered a line of therapy.
Descrizione

Line of Therapy Quantity | Induction Therapy | Salvage Therapy

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C4524693
UMLS CUI [1,2]
C1265611
UMLS CUI [2]
C0600558
UMLS CUI [3]
C0085405
5. age less than physiologic 65 years.
Descrizione

Age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001779
6. patients with an adequate autologous stem cell collection for transplantation (>2.5 x 106 cd34+ cells/kg). backup collection is preferable but not obligatory.
Descrizione

Stem cell collection Autologous Transplantation

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C3827940
UMLS CUI [1,2]
C0439859
UMLS CUI [1,3]
C0040732
7. patients must sign written informed consent.
Descrizione

Informed Consent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021430
8. adequate birth control in fertile patients.
Descrizione

Fertility Contraceptive methods

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0015895
UMLS CUI [1,2]
C0700589
9. all prior chemotherapy completed at least three weeks before study treatment
Descrizione

Prior Chemotherapy Completed

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1514457
UMLS CUI [1,2]
C0205197
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. chemo-refractory disease or more than 2 prior therapies
Descrizione

Chemotherapy Refractory Disease | Prior Therapy Quantity

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1514815
UMLS CUI [2,1]
C1514463
UMLS CUI [2,2]
C1265611
2. bilirubin > 3.0 mg/dl, transaminases > 3 times upper normal limit
Descrizione

Serum total bilirubin measurement | Serum transaminase increased

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1278039
UMLS CUI [2]
C0859350
3. creatinine > 2.0 mg/dl
Descrizione

Creatinine measurement, serum

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0201976
4. ecog-performance status < 2
Descrizione

ECOG performance status

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1520224
5. uncontrolled infection
Descrizione

Communicable Disease Uncontrolled

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C0205318
6. pregnancy or lactation
Descrizione

Pregnancy | Breast Feeding

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
7. abnormal lung diffusion capacity (dlco < 40% predicted)
Descrizione

Abnormal DLCO

Tipo di dati

boolean

Alias
UMLS CUI [1]
C4073173
8. severe cardiovascular disease
Descrizione

Cardiovascular Disease Severe

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0007222
UMLS CUI [1,2]
C0205082
9. chemo-refractory disease as determined by less than partial response to salvage chemotherapy.
Descrizione

Chemotherapy Refractory Disease | Partial response failed Salvage Chemotherapy

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1514815
UMLS CUI [2,1]
C1521726
UMLS CUI [2,2]
C0231175
UMLS CUI [2,3]
C0085405
UMLS CUI [2,4]
C0392920
10. active cns disease involvement
Descrizione

CNS disorder Involvement

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0007682
UMLS CUI [1,2]
C1314939
11. pleural effusion or ascites > 1 liter
Descrizione

Pleural effusion | Ascites

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0032227
UMLS CUI [2]
C0003962
12. known hypersensitivity to rituximab
Descrizione

Hypersensitivity Rituximab

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0393022
13. psychiatric conditions/disease that impair the ability to give informed consent or to adequately co-operate
Descrizione

Mental condition Impairing Informed Consent | Mental disorders Impairing Informed Consent | Mental condition Impairing Compliance behavior | Mental disorders Impairing Compliance behavior

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C3840291
UMLS CUI [1,2]
C0221099
UMLS CUI [1,3]
C0021430
UMLS CUI [2,1]
C0004936
UMLS CUI [2,2]
C0221099
UMLS CUI [2,3]
C0021430
UMLS CUI [3,1]
C3840291
UMLS CUI [3,2]
C0221099
UMLS CUI [3,3]
C1321605
UMLS CUI [4,1]
C0004936
UMLS CUI [4,2]
C0221099
UMLS CUI [4,3]
C1321605
Ritorna all'inizio della pagina

Similar models

Eligibility Non-Hodgkin's Lymphoma NCT00463463

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Aggressive Non-Hodgkin Lymphoma CD20 positive | Diffuse Large B-Cell Lymphoma | Transformation Follicular Lymphoma | Pathology biopsy report
Item
1. patients with cd20 positive aggressive non-hodgkin's lymphoma, either diffuse large b-cell or transformed follicular lymphoma as confirmed by a pathological biopsy report.
boolean
C1332225 (UMLS CUI [1,1])
C3888518 (UMLS CUI [1,2])
C0079744 (UMLS CUI [2])
C0040682 (UMLS CUI [3,1])
C0024301 (UMLS CUI [3,2])
C3165547 (UMLS CUI [4])
Stem cell transplantation Anticipated | First line Chemotherapy Refractory Disease | Recurrent disease | Transplantation Eligibility Criteria Fulfill
Item
2. patients who are candidates for stem-cell transplantation due to refractory disease to first line chemotherapy or relapsing disease and comply with standard transplant eligibility criteria.
boolean
C1504389 (UMLS CUI [1,1])
C3840775 (UMLS CUI [1,2])
C1708063 (UMLS CUI [2,1])
C0392920 (UMLS CUI [2,2])
C1514815 (UMLS CUI [2,3])
C0277556 (UMLS CUI [3])
C0040732 (UMLS CUI [4,1])
C1516637 (UMLS CUI [4,2])
C1550543 (UMLS CUI [4,3])
Chemosensitive malignant neoplastic disease | Partial response Salvage Chemotherapy
Item
3. patients must have chemo-sensitive disease achieving at least partial response to salvage chemotherapy.
boolean
C4520514 (UMLS CUI [1])
C1521726 (UMLS CUI [2,1])
C0085405 (UMLS CUI [2,2])
C0392920 (UMLS CUI [2,3])
Line of Therapy Quantity | Induction Therapy | Salvage Therapy
Item
4. patients were given up to 2 lines of therapy, initial treatment and one salvage treatment. local radiation therapy for consolidation is not considered a line of therapy.
boolean
C4524693 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0600558 (UMLS CUI [2])
C0085405 (UMLS CUI [3])
Age
Item
5. age less than physiologic 65 years.
boolean
C0001779 (UMLS CUI [1])
Stem cell collection Autologous Transplantation
Item
6. patients with an adequate autologous stem cell collection for transplantation (>2.5 x 106 cd34+ cells/kg). backup collection is preferable but not obligatory.
boolean
C3827940 (UMLS CUI [1,1])
C0439859 (UMLS CUI [1,2])
C0040732 (UMLS CUI [1,3])
Informed Consent
Item
7. patients must sign written informed consent.
boolean
C0021430 (UMLS CUI [1])
Fertility Contraceptive methods
Item
8. adequate birth control in fertile patients.
boolean
C0015895 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Prior Chemotherapy Completed
Item
9. all prior chemotherapy completed at least three weeks before study treatment
boolean
C1514457 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Chemotherapy Refractory Disease | Prior Therapy Quantity
Item
1. chemo-refractory disease or more than 2 prior therapies
boolean
C0392920 (UMLS CUI [1,1])
C1514815 (UMLS CUI [1,2])
C1514463 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
Serum total bilirubin measurement | Serum transaminase increased
Item
2. bilirubin > 3.0 mg/dl, transaminases > 3 times upper normal limit
boolean
C1278039 (UMLS CUI [1])
C0859350 (UMLS CUI [2])
Creatinine measurement, serum
Item
3. creatinine > 2.0 mg/dl
boolean
C0201976 (UMLS CUI [1])
ECOG performance status
Item
4. ecog-performance status < 2
boolean
C1520224 (UMLS CUI [1])
Communicable Disease Uncontrolled
Item
5. uncontrolled infection
boolean
C0009450 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
Pregnancy | Breast Feeding
Item
6. pregnancy or lactation
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Abnormal DLCO
Item
7. abnormal lung diffusion capacity (dlco < 40% predicted)
boolean
C4073173 (UMLS CUI [1])
Cardiovascular Disease Severe
Item
8. severe cardiovascular disease
boolean
C0007222 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
Chemotherapy Refractory Disease | Partial response failed Salvage Chemotherapy
Item
9. chemo-refractory disease as determined by less than partial response to salvage chemotherapy.
boolean
C0392920 (UMLS CUI [1,1])
C1514815 (UMLS CUI [1,2])
C1521726 (UMLS CUI [2,1])
C0231175 (UMLS CUI [2,2])
C0085405 (UMLS CUI [2,3])
C0392920 (UMLS CUI [2,4])
CNS disorder Involvement
Item
10. active cns disease involvement
boolean
C0007682 (UMLS CUI [1,1])
C1314939 (UMLS CUI [1,2])
Pleural effusion | Ascites
Item
11. pleural effusion or ascites > 1 liter
boolean
C0032227 (UMLS CUI [1])
C0003962 (UMLS CUI [2])
Hypersensitivity Rituximab
Item
12. known hypersensitivity to rituximab
boolean
C0020517 (UMLS CUI [1,1])
C0393022 (UMLS CUI [1,2])
Mental condition Impairing Informed Consent | Mental disorders Impairing Informed Consent | Mental condition Impairing Compliance behavior | Mental disorders Impairing Compliance behavior
Item
13. psychiatric conditions/disease that impair the ability to give informed consent or to adequately co-operate
boolean
C3840291 (UMLS CUI [1,1])
C0221099 (UMLS CUI [1,2])
C0021430 (UMLS CUI [1,3])
C0004936 (UMLS CUI [2,1])
C0221099 (UMLS CUI [2,2])
C0021430 (UMLS CUI [2,3])
C3840291 (UMLS CUI [3,1])
C0221099 (UMLS CUI [3,2])
C1321605 (UMLS CUI [3,3])
C0004936 (UMLS CUI [4,1])
C0221099 (UMLS CUI [4,2])
C1321605 (UMLS CUI [4,3])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial